Bruker Corporation

526 articles with Bruker Corporation

• Bruker Announces Two 1.2 GHz NMR Systems Orders from the UK

  3/17/2023

  Bruker announces that the United Kingdom is expanding its fundamental research infrastructure with recent orders for two .2 GHz Avance ™ nuclear magnetic resonance (NMR) spectrometers for the University of Warwick and the University of Birmingham.

• Bruker Launches de novo Sequencing for Immunopeptidomics, Library-Free dia-PASEF, Mass Dynamics Knowledge Visualization

  3/6/2023

  At the 19th US HUPO, Bruker Corporation announced important bioinformatics launches for 4D-Proteomics on the timsTOF platform: A novel de novo sequencing algorithm was developed in collaboration with Rapid Novor Inc., using over 1.7 million PASEF data-points to improve accuracy and speed for immunopeptidomics in real-time.

• Bruker Announces Quarterly Dividend - February 17, 2023

  2/17/2023

  Bruker Corporation announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company’s common stock.

• Bruker Reports Fourth Quarter and Fiscal Year 2022 Financial Results

  2/9/2023

  Bruker Corporation (Nasdaq: BRKR) today announced financial results for its fourth quarter and for the fiscal year ended December 31, 2022.

• Bruker Announces Successful Customer Installations of First Two Compact 1.0 GHz NMR Systems to Advance Structural Biology

  2/3/2023

  Bruker today announced successful customer installations of two novel, compact 1.0 GHz NMR spectrometers for advanced structural and molecular biology applications well ahead of original schedules in late 2022.

• Bruker Announces Date and Time of Fourth Quarter 2022 Earnings Release and Webcast

  1/31/2023

  Bruker Corporation announced it will report fourth quarter and fiscal year 2022 financial results before market opening on Thursday, February 9, 2023.

• Bruker Announces Acquisition of ACQUIFER Imaging GmbH

  1/5/2023

  Bruker Corporation announced the acquisition of ACQUIFER Imaging GmbH, a pioneer in big-data management solutions for bioimaging and high-content microscopy.

• Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers

  1/4/2023

  New strategic partnership aims to broaden access to Biognosys’ leading CRO services and Spectronaut® software tools for unbiased proteomics and epiproteomics.

• Bruker Corporation to Present at the 41st Annual J.P. Morgan Healthcare Conference

  12/21/2022

  Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 41st annual J.P. Morgan Healthcare Conference in San Francisco. Frank Laukien, Chairman, President & CEO, Mark Munch, Executive Vice President & President of Bruker Nano Group, and Gerald Herman, Executive Vice President & CFO will present on behalf of the Company on Monday, January 9th, 2023 at 10:30 AM Eastern Standard Time.

• Bruker Energy & Supercon Technologies (BEST) Announces Multi-Year Orders for Key Magnetic Confinement Fusion Technologies

  12/16/2022

  Bruker Corporation announced that its Bruker Energy & Supercon Technologies division, and majority-owned RI Research Instruments GmbH have received multi-year contracts to supply key technology components for major fusion projects in Europe and Asia, together valued at approximately $50 million.

• Bruker Announces Quarterly Dividend - November 11, 2022

  11/11/2022

  Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company’s common stock.

• Bruker Announces Acquisition of Inscopix for Neuroscience Research

  11/8/2022

  Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of Inscopix, Inc., a neuroscience pioneer and market leader of miniaturized microscopes, known as miniscopes, for freely moving animal brain imaging.

• Bruker Corporation to Participate in the 2022 Jefferies London Healthcare Conference

  11/7/2022

  Bruker Corporation announced it will participate in the 2022 Jefferies London Healthcare Conference.

• Bruker Reports Third Quarter 2022 Financial Results

  11/3/2022

  Bruker Corporation (Nasdaq: BRKR) today announced financial results for its third quarter and for the nine months ended September 30, 2022.

• Bruker Announces Date and Time of Third Quarter 2022 Earnings Release and Webcast

  10/21/2022

  Bruker Corporation (Nasdaq: BRKR) today announced it will report third quarter 2022 financial results before market opening on Thursday, November 3, 2022.

• Bruker Launches New nanoElute® 2 nano-LC For 4D-Proteomics, Advances Fluxomics Applications with MetaboScape®2023 Software

  8/29/2022

  At the International Mass Spectrometry Conference, Bruker Corporation announced the launch of the new nanoElute® 2 nano-LC, of MetaboScape® and TASQ® 2023 software supporting fluxomics, and of latest advances in PaSER™’s intelligent acquisition to enhance research in protein-protein interactions and metaproteomics applications.

• Bruker Introduces Enabling New Scientific Capabilities for Cell Biology and Pathobiology Research with High-Field NMR Innovations

  8/22/2022

  At the ICMRBS 2022 Conference, Bruker today announces a new 8 mm 15 N TROSY Cryoprobe for enabling novel NMR functional structural biology investigations into larger globular proteins and protein complexes.

• Bruker Announces Quarterly Dividend - Aug 12, 2022

  8/12/2022

  Bruker Corporation announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company’s common stock.

• Bruker Reports Second Quarter 2022 Financial Results

  8/3/2022

  Bruker Corporation announced financial results for its second quarter and for the six months ended June 30, 2022.

• Bruker Announces Date and Time of Second Quarter 2022 Earnings Release and Webcast

  7/25/2022

  Bruker Corporation (Nasdaq: BRKR) today announced it will report second quarter 2022 financial results after market close on Wednesday, August 3, 2022.